<p>Differentially expressed genes, with mifepristone treatment: Genes, their cellular location and the fold changes with mifepristone treatment on leiomyoma patients as analysed by microarray followed by IPA.</p
<p>Microarray data for selected genes after Sf9 treatment by methoxyfenozide.</p
1<p>Fold change was calculated as mean methylation beadchip value for leiomyoma relative to normal m...
Uterine leiomyoma (UL) is a benign tumor arising from myometrium (MM) with a high prevalence and unc...
<p>Glutathione pathway gene expression and leiomyoma volume reduction: Expression levels and fold ch...
gene in leiomyoma biopsies was found in 50% of the mifepristone treated cases, with lower presence ...
gene in leiomyoma biopsies was found in 50% of the mifepristone treated cases, with lower presence ...
Progesterone receptor modulators, such as mifepristone are useful and well tolerated in reducing lei...
Progesterone receptor modulators, such as mifepristone are useful and well tolerated in reducing lei...
<div><p></p><p>Progesterone receptor modulators, such as mifepristone are useful and well tolerated ...
<p>GR-good responders (>30% volume reduction); PR-poor responders (<18% volume reduction).</p>*<p>no...
<p>The fold change was calculated as values of leiomyoma relative to adjacent myometrium in each cas...
Human uterine leiomyomas (ULM) are characterized by dysregulation of a large number of genes and non...
1<p>Fold change was calculated as mean methylation beadchip value for leiomyoma relative to normal m...
<p><b>Copyright information:</b></p><p>Taken from "Genomic and proteomic profiling II: Comparative a...
Uterine leiomyomas are tumors, which are hormone driven and originate from the smooth muscle layer o...
<p>Microarray data for selected genes after Sf9 treatment by methoxyfenozide.</p
1<p>Fold change was calculated as mean methylation beadchip value for leiomyoma relative to normal m...
Uterine leiomyoma (UL) is a benign tumor arising from myometrium (MM) with a high prevalence and unc...
<p>Glutathione pathway gene expression and leiomyoma volume reduction: Expression levels and fold ch...
gene in leiomyoma biopsies was found in 50% of the mifepristone treated cases, with lower presence ...
gene in leiomyoma biopsies was found in 50% of the mifepristone treated cases, with lower presence ...
Progesterone receptor modulators, such as mifepristone are useful and well tolerated in reducing lei...
Progesterone receptor modulators, such as mifepristone are useful and well tolerated in reducing lei...
<div><p></p><p>Progesterone receptor modulators, such as mifepristone are useful and well tolerated ...
<p>GR-good responders (>30% volume reduction); PR-poor responders (<18% volume reduction).</p>*<p>no...
<p>The fold change was calculated as values of leiomyoma relative to adjacent myometrium in each cas...
Human uterine leiomyomas (ULM) are characterized by dysregulation of a large number of genes and non...
1<p>Fold change was calculated as mean methylation beadchip value for leiomyoma relative to normal m...
<p><b>Copyright information:</b></p><p>Taken from "Genomic and proteomic profiling II: Comparative a...
Uterine leiomyomas are tumors, which are hormone driven and originate from the smooth muscle layer o...
<p>Microarray data for selected genes after Sf9 treatment by methoxyfenozide.</p
1<p>Fold change was calculated as mean methylation beadchip value for leiomyoma relative to normal m...
Uterine leiomyoma (UL) is a benign tumor arising from myometrium (MM) with a high prevalence and unc...